New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 21, 2014
10:01 EDTSQBK, SLMVV, NAVIV, ATEN, PCRX, AHP, TWOU, ATO, AGTCOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 2U (TWOU) initiated with a Buy at Compass Point... A10 Networks (ATEN) initiated with a Buy at Citigroup... Applied Genetic (AGTC) initiated with a Buy at Cantor... Ashford Hospitality Prime (AHP) initiated with a Hold at Deutsche Bank... Atmos Energy (ATO) initiated with a Neutral at JPMorgan... Navient (NAVIV) initiated with a Buy at Goldman... Pacira Pharmaceuticals (PCRX) initiated with a Buy at BofA/Merrill... Puma Biotechnology (PBYI) initiated with a Buy at Citigroup... Sallie Mae Bank (SLMVV) initiated with a Neutral at Goldman... Square 1 Financial (SQBK) initiated with a Market Perform at Keefe Bruyette.
News For TWOU;ATEN;AGTC;AHP;NAVIV;ATO;PCRX;SLMVV;SQBK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
06:31 EDTPCRXPacira announces positive data in study of Exparel
Subscribe for More Information
March 23, 2015
16:32 EDTPCRXPacira announces results of two data presentations for Exparel
Pacira Pharmaceuticals announced results of two data presentations on the impact of Exparel on postsurgical opioid requirements in patients undergoing hysterectomy or mastectomy. The data were presented during two poster sessions at the annual meeting of the International Anesthesia Research Society, or IARS, being held in Honolulu March 21-24. The first study compared the efficacy of Exparel to bupivacaine HCl when infiltrated into the transversus abdominis plane, or TAP, to provide postsurgical analgesia following robotic assisted hysterectomy in 60 women. Blinded assessments of pain intensity, opioid intake and incidence of adverse events were taken for up to 72 hours after the procedure. In comparison to the bupivacaine HCl treatment group, patients who received TAP infiltration with Exparel had: Significantly decreased total opioid intake in first 72 hours; Significantly decreased incidence of nausea and vomiting in the first 72 hours; Significantly lower maximal pain intensity at all time points.
March 20, 2015
10:12 EDTTWOU2U management to meet with Oppenheimer
Subscribe for More Information
March 19, 2015
07:18 EDTAGTCGlobal Technology Community to hold a conference
7th Ocular Diseases Drug Discovery Conference is being held in San Diego, California on March 19-20.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use